Development of a rapid GC-FID method to simultaneously determine triethylamine, diisopropylamine, and 1,1,3,3-tetramethylguanidine residues in an active pharmaceutical ingredient

A rapid GC-FID method was developed to simultaneously determine residual levels of triethylamine (TEA), 1,1,3,3-tetramethylguanidine (TMG), and diisopropylamine (DIPA) in the synthetic route of an active pharmaceutical ingredient (API). Due to the severe absorption of amines on GC stationary phases,...

Full description

Saved in:
Bibliographic Details
Main Authors: Minshan Shou (Author), Haixiao Qiu (Author)
Format: Book
Published: Elsevier, 2021-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_db39d84d8c9d4a1b81a2bac3eaf4c7c9
042 |a dc 
100 1 0 |a Minshan Shou  |e author 
700 1 0 |a Haixiao Qiu  |e author 
245 0 0 |a Development of a rapid GC-FID method to simultaneously determine triethylamine, diisopropylamine, and 1,1,3,3-tetramethylguanidine residues in an active pharmaceutical ingredient 
260 |b Elsevier,   |c 2021-04-01T00:00:00Z. 
500 |a 2095-1779 
500 |a 10.1016/j.jpha.2020.06.007 
520 |a A rapid GC-FID method was developed to simultaneously determine residual levels of triethylamine (TEA), 1,1,3,3-tetramethylguanidine (TMG), and diisopropylamine (DIPA) in the synthetic route of an active pharmaceutical ingredient (API). Due to the severe absorption of amines on GC stationary phases, GC columns with various stationary phases were evaluated for optimal peak shape and reproducibility. The final conditions used the Agilent CP-Volamine column to resolve the three amines in 12 min. Various inlet liners were also screened to further improve the sensitivity of the analysis. The Restek Siltek® liner was selected to achieve the desired detectability for the method. The quantitation limits were 4, 3, and 4 μg/mL for TEA, DIPA, and TMG in the presence of API, respectively. All three amines showed good linearity (r > 0.999) and recoveries (> 90%) over the concentration range of 3 to 16 μg/mL. The testing of residual amines was initially performed at the penultimate stage of the synthesis. However, this work demonstrates that TMG can act as a proton sponge to react with salicylic acid, the counter ion of the penultimate, to form a volatile component that elutes at a different retention time. Consequently, in the final method, these three amines were monitored in the final API to circumvent the matrix interference. Key parameters of the method were qualified per method validation requirements in ICH guidelines. The method was successfully applied for batch testing during development and implemented as an in-process control procedure at manufacturing sites. 
546 |a EN 
690 |a GC-FID 
690 |a Amines 
690 |a API 
690 |a Method development 
690 |a Method qualification 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmaceutical Analysis, Vol 11, Iss 2, Pp 251-256 (2021) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2095177919310809 
787 0 |n https://doaj.org/toc/2095-1779 
856 4 1 |u https://doaj.org/article/db39d84d8c9d4a1b81a2bac3eaf4c7c9  |z Connect to this object online.